Industry

DUBLIN–(BUSINESS WIRE)–The “Bacterial Conjunctivitis – Market Insight, Epidemiology and Market Forecast -2032” report has been added to ResearchAndMarkets.com’s offering. This report delivers an in-depth understanding of the Bacterial Conjunctivitis, historical and forecasted epidemiology as well as the Bacterial Conjunctivitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Medical Imaging Market Research Report by Modality (Computed Tomography, Fluoroscopy, and Mammography), End-user, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Medical Imaging Market size was estimated at USD 16.84 billion in … [Read more…]

HONG KONG & INGELHEIM, Germany–(BUSINESS WIRE)–Hong Kong Science and Technology Parks Corporation (HKSTP) is partnering global research-driven biopharmaceutical leader, Boehringer Ingelheim Venture Fund Limited (BIVF) in a strategic co-incubation collaboration to promote and nurture startups on research and development for infectious diseases and immunology. HKSTP is dedicated to collaborating with sector leaders in building the … [Read more…]

IFPMA, the body representing biopharmaceutical companies in Geneva, expresses deep disappointment with the decision taken to adopt a TRIPS waiver, despite intellectual property (IP) not being a barrier to vaccine scale-up and wide acknowledgment of vaccines surplus. IP has enabled the rapid research and development of several effective vaccines against COVID-19 and underpinned the more … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Microneedle Measurable Chronic Disease Biomarkers” report has been added to ResearchAndMarkets.com’s offering. Biomarkers are a key medical product development tool capable of facilitating development of medical products and spurring innovation. When used in the right context, biomarkers have the potential to help expedite patient access to safe and effective treatments by reducing the … [Read more…]

Seoul Semiconductor Ranked Top ANSAN, South Korea–(BUSINESS WIRE)–#KOSDAQ046890—Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a global optical semiconductor company, announced that Seoul Semiconductor and Seoul Viosys (hereafter referred to as Seoul) are Korea’s #1 optical semiconductor (LED) companies and are among the world’s #1 patent-powered companies. Seoul is ranked first in the world in the ultraviolet … [Read more…]

Jon Parr, President, Global Crop Protection, to retire in September 2022 after 35 years of service Jeff Rowe, currently President, Global Seeds, to become President, Global Crop Protection Justin Wolfe, Regional Director North America Seeds to become President, Global Seeds Matthew Johnston, Head of Vegetable Seeds and Flowers, to report directly to CEO Erik Fyrwald … [Read more…]

EMERYVILLE, Calif.–(BUSINESS WIRE)–SLINGSHOT BIOSCIENCES, INC. the makers of synthetic cells that bring consistent precision and accurate control to replace inconsistent blood and tissue controls for use in flow cytometry and other biotech markets, today announced they have extended their distribution channel through a new agreement with Ozyme, a French company dedicated to the supply of … [Read more…]

Joint venture will construct and operate a 52-bed hospital in Irvine ORANGE, Calif. & BRENTWOOD, Tenn.–(BUSINESS WIRE)–UCI Health and Kindred Rehabilitation Services (“KRS”), a business unit of LifePoint Health, today announced that they have signed a definitive agreement to create a joint venture to construct and operate a 52-bed, 68,000 sq. ft. inpatient rehabilitation hospital … [Read more…]

BURLINGTON, Ontario–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (“RDT”), (CSE: DOSE), a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, announces that it will not be in a position to file its audited annual financial statements for the fiscal year ended February 28, 2022, including the related management’s discussion and analysis and CEO and CFO … [Read more…]